Biopharmaceutical informatics calls for the use of computational technologies such as AI/ML, digitalization, and molecular simulations to curate, analyze, visualize and interpret experimental data and provide data-informed inputs at every stage of biologic drug discovery and development projects. This interdisciplinary endeavor enables in-project as well as across project learnings from the laboratory results and also allows for disruptive innovations to accelerate biologic drug discovery. In recent years, biopharmaceutical informatics has emerged as a field of its own as the use of computation in biologic drug discovery and development has steadily increased, thereby, revolutionizing how we discover and develop biologic drugs.
Our virtual Biopharmaceutical Informatics Symposium, organized by Drs. Sandeep Kumar and Victor Greiff, will address questions about how we can bring novel biotherapeutic products to patients more often, faster and at affordable costs using biopharmaceutical informatics. Our expert speakers include Lucy Colwell (Google Research) Konrad Krawczyk (Natural Antibody), Peter Tessier (University of Michigan), and Charlotte Deane (University of Oxford). We will also have a panel discussion with the speakers and Ajay Royyuru (IBM), and Andrew E. Nixon (Boehringer Ingelheim Pharmaceutical Inc.).
